ASPIRA PATHLAB & DIAGNOSTICS
|
ASPIRA PATHLAB & DIAGNOSTICS Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Profit Before Tax | ₹2.02 Cr | ₹-2.67 Cr |
| Adjustment | ₹1.78 Cr | ₹1.77 Cr |
| Changes In working Capital | ₹-1.97 Cr | ₹1.96 Cr |
| Cash Flow after changes in Working Capital | ₹1.83 Cr | ₹1.05 Cr |
| Cash Flow from Operating Activities | ₹1.83 Cr | ₹1.05 Cr |
| Cash Flow from Investing Activities | ₹0.12 Cr | ₹0.14 Cr |
| Cash Flow from Financing Activities | ₹-0.99 Cr | ₹-0.95 Cr |
| Net Cash Inflow / Outflow | ₹0.95 Cr | ₹0.24 Cr |
| Opening Cash & Cash Equivalents | ₹0.80 Cr | ₹0.57 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - |
| Effect of Foreign Exchange Fluctuations | - | - |
| Closing Cash & Cash Equivalent | ₹1.75 Cr | ₹0.80 Cr |
Compare Cashflow Statement of peers of ASPIRA PATHLAB & DIAGNOSTICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASPIRA PATHLAB & DIAGNOSTICS | ₹123.3 Cr | 1.3% | 20.2% | 106.3% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹121,241.0 Cr | -0.8% | 5.1% | 21.1% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹99,869.4 Cr | 1.7% | -3.1% | -13.6% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹71,709.7 Cr | -4% | -1.3% | 26.8% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹39,716.6 Cr | -5.9% | 1.5% | 36.6% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹37,662.7 Cr | -1% | -1.3% | 1.5% | Stock Analytics | |
ASPIRA PATHLAB & DIAGNOSTICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASPIRA PATHLAB & DIAGNOSTICS | 1.3% |
20.2% |
106.3% |
| SENSEX | 4.3% |
2.6% |
-6.4% |
You may also like the below Video Courses